Nystatin for Oral Candidiasis

Generic name: Nystatin

German term: Nystatin bei oraler Candidose / Mundsoor

Category: Polyene antifungal; topical oral antifungal suspension

Dental role: Treatment of oral candidiasis / oral thrush when topical therapy is appropriate

Common form: Oral suspension, commonly 100,000 units/mL. Some labels describe adults and children using several mL four times daily, while UK guidance commonly uses 1 mL four times daily. Always follow the local product label or prescriber instruction.

This article is for dental education only. Nystatin is useful for selected oral Candida infections, but it is not treatment for bacterial dental abscess, herpes infection, aphthous ulcers, leukoplakia, oral cancer, allergic stomatitis, or traumatic ulcers. Persistent white patches, red lesions, ulcers, pain, dysphagia, or recurrent thrush require diagnosis and risk-factor assessment rather than repeated antifungal self-treatment.

Nystatin is a topical antifungal used for oral candidiasis. It acts locally in the mouth and is absorbed very little from the gastrointestinal tract, which makes it useful for superficial oral Candida infection when systemic treatment is not required.

In dental practice, nystatin is most relevant for pseudomembranous candidiasis, erythematous candidiasis, denture-related Candida infection, and Candida overgrowth related to antibiotics, inhaled corticosteroids, xerostomia, immunosuppression, or poor denture hygiene.

The key clinical principle is: treat the fungus and remove the cause. Antifungal medication works better when denture hygiene, dry mouth, diabetes control, inhaler technique, smoking, and local trauma are also addressed.

• Best dental use: mild to moderate oral candidiasis when topical therapy is appropriate
• Common context: denture stomatitis, antibiotic-associated thrush, steroid inhaler-related thrush, xerostomia, elderly patients, and medically complex patients
• Main advantage: local antifungal action with minimal systemic absorption
• Main limitation: needs repeated daily dosing and adequate contact time with oral mucosa
• Clinical priority: check for red flags, remove predisposing factors, and review if not improving

Nystatin binds to sterols in the fungal cell membrane. This changes membrane permeability and causes leakage of intracellular components, damaging Candida cells.

• Local effect: the suspension must contact the infected oral mucosa.
• Minimal absorption: nystatin is absorbed very poorly from the gut at recommended doses.
• Not systemic therapy: it is not appropriate for systemic mycoses or deep fungal infection.
• Adherence dependent: benefit depends on correct dosing, shaking the bottle, swishing, and contact time.
• Important: if esophageal symptoms are present, topical nystatin alone may be insufficient and medical assessment is needed.

• Oral thrush / pseudomembranous candidiasis with wipeable white plaques
• Erythematous candidiasis with red, sore, burning mucosa when Candida is likely
• Denture stomatitis as part of a plan including denture cleaning and night-time denture removal
• Angular cheilitis when Candida contributes, usually with local cause control
• Thrush after broad-spectrum antibiotics when clinically consistent
• Thrush related to inhaled corticosteroids when inhaler technique and mouth rinsing are corrected
• Supportive management in xerostomia-related Candida overgrowth
• Alternative when miconazole gel is unsuitable because of interaction or safety concerns, depending on local guidance

Common instruction concept: shake the bottle, measure the correct dose, place the liquid in the mouth, keep it in contact with the affected areas as long as possible, then swallow or spit according to the prescription.

Frequency: many regimens use four daily doses. Some labels and countries use different volumes, so the local prescription and product label are decisive.

Important timing: use after meals and before bedtime when instructed, and avoid eating or drinking shortly after dosing so the medicine stays in contact with the mucosa.

• Poor denture hygiene or sleeping with dentures
• Ill-fitting denture causing chronic mucosal trauma
• Recent antibiotic course
• Inhaled corticosteroid without mouth rinsing after use
• Xerostomia from medications, Sjögren syndrome, radiotherapy, or dehydration
• Uncontrolled diabetes
• Smoking
• Immunosuppression, chemotherapy, HIV risk, or systemic illness
• High sugar frequency and poor plaque control
• Use of topical steroids in the mouth without antifungal monitoring when indicated

• Nystatin: topical oral suspension; useful locally; needs repeated dosing and good contact time.
• Miconazole oral gel: topical option but can have important drug interactions, especially with warfarin and some other medicines.
• Fluconazole: systemic antifungal; often used when disease is moderate, severe, recurrent, refractory, or when topical therapy is unsuitable.
• Key decision: do not escalate antifungals without confirming diagnosis, risk factors, interactions, pregnancy status, liver risk, and systemic symptoms.

• Undiagnosed white or red-white lesion where leukoplakia, dysplasia, or malignancy is possible
• Persistent ulcer or lesion lasting more than two weeks without clear diagnosis
• Suspected herpes infection, aphthous ulcer, traumatic ulcer, allergic reaction, or lichen planus without Candida evidence
• Esophageal symptoms such as dysphagia, odynophagia, chest pain, or food sticking
• Severe or recurrent candidiasis without investigating diabetes, immunosuppression, xerostomia, medications, or denture factors
• Known hypersensitivity to nystatin or product ingredients
• As treatment for systemic fungal infection
• As repeated self-treatment without dental or medical review
• When symptoms worsen or do not improve after an appropriate course

• Hypersensitivity to nystatin or any component of the suspension
• Need for systemic antifungal therapy because infection is not limited to the oral cavity
• Marked immunosuppression with severe, recurrent, or atypical oral lesions requiring medical coordination
• Suspected esophageal candidiasis requiring systemic assessment and treatment
• Unclear diagnosis where antifungal treatment may delay biopsy or specialist referral
• Patients with diabetes or xerostomia where the underlying driver must be managed
• Use in infants, pregnancy, or breastfeeding only according to local prescribing guidance and clinician judgment
• Difficulty using the suspension correctly because of swallowing, cognition, or cooperation problems

• Not for systemic mycoses: nystatin oral suspension is a local therapy, not a systemic antifungal.
• Contact time matters: swallowing immediately reduces oral mucosal contact and may reduce benefit.
• Denture reservoir: untreated dentures can re-infect the mouth.
• Steroid inhalers: rinse the mouth after inhaled corticosteroids to reduce recurrence risk.
• Recurrent thrush: may signal diabetes, xerostomia, immune compromise, medication effect, or poor denture hygiene.
• Persistent lesions: if the lesion does not resolve, reassess and consider referral.
• Sugar content: some suspensions may contain sugar or sweeteners; consider caries risk in high-risk patients.

The biggest nystatin mistake is treating every white lesion as thrush. Wipeable white plaques with erythematous mucosa may fit candidiasis, but fixed white patches, red-white lesions, indurated ulcers, or persistent unilateral lesions need diagnosis and possible referral.

• Unpleasant taste or aftertaste
• Nausea or stomach upset
• Vomiting or diarrhea in some patients
• Oral irritation or sensitization
• Rash, itching, swelling, wheezing, or allergy-type symptoms in rare cases
• Reduced adherence because of repeated dosing or taste
• Ongoing symptoms if the underlying denture, xerostomia, diabetes, or medication factor is not corrected

• Shake the bottle well before each dose.
• Use a proper measuring syringe or spoon, not a kitchen spoon.
• Hold the liquid in the mouth and move it around the affected areas before swallowing or spitting as instructed.
• Avoid eating or drinking for about 30 minutes after the dose if instructed, so the medicine stays on the mucosa.
• Take the medicine for the full prescribed course and continue briefly after improvement if instructed.
• Clean dentures daily, remove them at night, and disinfect them according to dental advice.
• Rinse the mouth after inhaled steroid use.
• Control dry mouth, plaque, sugar frequency, and smoking risk factors.
• Contact the dentist or doctor if symptoms do not improve, keep returning, or swallowing becomes painful.
• Stop and seek advice if rash, swelling, wheezing, severe irritation, or allergic symptoms occur.

Nystatin treats the oral Candida load, but the recurrence risk is controlled by fixing the local environment: clean dentures, dry mouth management, inhaler hygiene, diabetes control, smoking cessation, and reduced sugar frequency.

• Dysphagia, odynophagia, chest pain, or suspected esophageal candidiasis
• White, red, or ulcerated lesion persisting more than two weeks
• Indurated ulcer, unexplained bleeding, unilateral lesion, or suspicious red-white patch
• Recurrent oral candidiasis without obvious local cause
• Severe immunosuppression, uncontrolled diabetes, or systemic illness
• Facial swelling, fever, pus, or odontogenic infection signs
• Allergic symptoms such as swelling, wheezing, rash, or breathing difficulty
• Infant or frail patient with poor feeding, dehydration, or spreading infection concerns

• Miconazole oral gel
• Fluconazole
• Clotrimazole
• Denture stomatitis
• Oral candidiasis
• Angular cheilitis
• Xerostomia
• Inhaled corticosteroids
• Diabetes and oral infections
• Persistent white oral lesions

Nystatin is a topical polyene antifungal used in dentistry mainly for oral candidiasis. It is useful for mild to moderate oral thrush when the infection is limited to the oral cavity and the patient can use the suspension correctly. Its success depends on oral contact time, repeated dosing, completing the course, denture hygiene, and correction of predisposing factors such as xerostomia, antibiotics, inhaled corticosteroids, diabetes, smoking, and poor oral hygiene. Nystatin is not a systemic antifungal and should not be used to treat esophageal symptoms, systemic fungal infection, suspicious persistent oral lesions, or unexplained red-white patches without proper assessment. Recurrent or non-resolving candidiasis should trigger review of diagnosis, medications, dentures, immune status, glucose control, and referral when needed.